Log on / register
Feedback | Support | My details

Comments

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

Jeanne C Latourelle email, Mei Sun email, Mark F Lew email, Oksana Suchowersky email, Christine Klein email, Lawrence I Golbe email, Margery H Mark email, John H Growdon email, G Frederick Wooten email, Ray L Watts email, Mark Guttman email, Brad A Racette email, Joel S Perlmutter email, Anwar Ahmed email, Holly A Shill email, Carlos Singer email, Stefano Goldwurm email, Gianni Pezzoli email, Michela Zini email, Marie H Saint-Hilaire email, Audrey E Hendricks email, Sally Williamson email, Michael W Nagle email, Jemma B Wilk email, Tiffany Massood email, Karen W Huskey email, Jason M Laramie email, Anita L DeStefano email, Kenneth B Baker email, Ilia Itin email, Irene Litvan email, Garth Nicholson email, Alastair Corbett email, Martha Nance email, Edward Drasby email, Stuart Isaacson email, David J Burn email, Patrick F Chinnery email, Peter P Pramstaller email, Jomana Al-hinti email, Anette T Moller email, Karen Ostergaard email, Scott J Sherman email, Richard Roxburgh email, Barry Snow email, John T Slevin email, Franca Cambi email, James F Gusella email and Richard H Myers email

BMC Medicine 2008, 6:32doi:10.1186/1741-7015-6-32

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.